PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
P Beck-Peccoz Selected Research
Thyrotropin (Thyroid-Stimulating Hormone)
04/2001
Hyperplastic pituitary gland, high serum glycoprotein hormone alpha-subunit, and variable circulating thyrotropin (TSH) levels as hallmark of central hypothyroidism due to mutations of the TSH beta gene.
04/2001
Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan's syndrome: characterization of TSH carbohydrate content and bioactivity.
01/2001
Serum thyrotropin concentrations and bioactivity during sleep deprivation in depression.
10/2000
Circulating thyrotropin bioactivity in sporadic central hypothyroidism.
04/2000
Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.
Articles by Research Topic
Disease
7
Acromegaly
10/2007 - 08/2001
3
Neoplasms (Cancer)
01/2008 - 09/2006
3
Hypothyroidism
04/2001 - 10/2000
2
Graves Ophthalmopathy
04/2008 - 02/2008
2
Pituitary Neoplasms (Pituitary Adenoma)
05/2002 - 04/2000
1
Cushing Syndrome
11/2007
1
Primary Hyperparathyroidism
11/2006
1
Sleep Apnea Syndromes (Sleep Apnea)
09/2006
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2006
1
Carcinoma (Carcinomatosis)
10/2005
1
Fetal Growth Retardation (Intrauterine Growth Retardation)
11/2004
1
Adrenal Insufficiency (Adrenal Gland Hypofunction)
09/2004
1
Adenoma (Adenomas)
04/2004
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
07/2003
1
Insulin Resistance
06/2003
1
Hyperthyroidism
09/2001
1
Breast Neoplasms (Breast Cancer)
06/2001
1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
04/2001
1
Hypopituitarism (Sheehan's Syndrome)
04/2001
1
Sleep Deprivation
01/2001
Drug/Important Bio-Agent (IBA)
5
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
03/2007 - 04/2000
5
Thyrotropin (Thyroid-Stimulating Hormone)
FDA Link
04/2001 - 04/2000
4
Ghrelin
IBA
03/2006 - 07/2003
2
lanreotide (Somatuline)
FDA Link
10/2007 - 04/2000
2
Octreotide (Sandostatin)
FDA Link
Generic
10/2007 - 09/2006
2
Insulin-Like Growth Factor I (IGF-1)
IBA
03/2007 - 08/2001
2
somatostatin receptor 2
IBA
09/2006 - 08/2005
2
Glycoproteins (Glycoprotein)
IBA
04/2001 - 04/2001
2
Hormones
IBA
04/2001 - 04/2001
1
Immunologic Factors (Immunomodulators)
IBA
04/2008
1
rituximab (Mabthera)
FDA Link
02/2008
1
Hydrocortisone (Cortisol)
FDA Link
Generic
01/2008
1
Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
IBA
01/2008
1
Messenger RNA (mRNA)
IBA
11/2007
1
Pro-Opiomelanocortin (Proopiomelanocortin)
IBA
11/2007
1
pegvisomant
FDA Link
Generic
09/2007
1
Calcium-Sensing Receptors
IBA
11/2006
1
Calcium
IBA
11/2006
1
Adiponectin
IBA
09/2006
1
inhibin A
IBA
11/2004
1
activin A
IBA
11/2004
1
inhibin B
IBA
11/2004
1
Dehydroepiandrosterone (DHEA)
IBA
09/2004
1
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
04/2004
1
Pancreatic Hormones
IBA
01/2004
1
Glucose (Dextrose)
FDA Link
Generic
06/2002
1
Gonadotropins
IBA
05/2002
1
Estrogens (Estrogen)
FDA Link
05/2002
1
Thyrotropin Receptors (Thyrotropin Receptor)
IBA
09/2001
1
Insulin-Like Growth Factor Binding Protein 3
IBA
08/2001
1
Prolactin
IBA
06/2001
1
beta Subunit Thyrotropin (Thyrotropin-beta)
IBA
04/2001
Therapy/Procedure
1
Aftercare (After-Treatment)
06/2003